BUZZ
Experts have raised concerns about safety issues of the drug
Young women at the University of Oregon will soon be able to walk into their campus health clinic and get drugs to kill their preborn babies, following advocacy from pro-abortion groups.
The University of Oregon announced it will hand out the abortion drugs this upcoming fall.
“UHS is committed to ensuring students have access to timely, comprehensive reproductive care,” spokesperson Angela Seydel told KLCC, using a euphemism for abortion.
“Expanding our services to include medication abortion is the next necessary step in that commitment,” she said.
Groups on campus including the Young Democratic Socialists and Students for Choice pressured the university through petitions and activism, The College Fix previously reported. The student government also pushed for the drugs.
The university previously declined to offer the drugs, which aim to kill preborn babies in the womb before 12 weeks gestation, due to concerns about safety.
“Specifically, [University Health Services] noted they did not have a full-time staff member on call 24/7 to aid students undergoing side effects,” The Daily Emerald reported.
View this post on Instagram
In addition to ending a human life, experts have raised concerns about the harmful side effects on women when they take the abortion drugs.
“It is deeply irresponsible for pro-abortion agitators to attempt to push the University of Oregon to distribute abortion pills on campus,” Oregon Right for Life previously told The College Fix.
“Chemical abortion is lethal for unborn babies and very dangerous for women, as recent research has shown,” Communications Director Ashley Sadler said in January.
Sadler noted a study by the Ethics and Public Policy Center found “more than one out of every ten women (10.93%) experiences a severe adverse event after taking Mifepristone, with an abortion pill-related emergency room visit rate of nearly one in 20 (4.7%).”
The same think tank released a report on March 10 which further confirmed its findings. The group noted an increase in “serious adverse events” after the Food and Drug Administration, under President Joe Biden, decided women no longer needed to see a doctor before taking the drugs.
